Showing results (61-70 of 136) with videos related to

Sort By:
Pageof 14
Haematologica|July 18, 2012
Randomized phase IIb study of low-dose cytarabine and lintuzumab versus low-dose cytarabine and placebo in older adults with untreated acute myeloid leukemiaMikkael A Sekeres, Jeffrey E Lancet, Brent L Wood, et al.
Circulation|October 7, 1997
Serum cholesterol and mortality rates in a Native American population with low cholesterol concentrations: a U-shaped associationA Fagot-Campagna, R L Hanson, K M Narayan, et al.
Leukemia|December 1, 1995
Cell surface expression of the multidrug resistance P-glycoprotein (P-170) as detected by monoclonal antibody MRK-16 in pediatric acute myeloid leukemia fails to define a poor prognostic group: a report from the Childrens Cancer GroupE L Sievers, F O Smith, W G Woods, et al.
Mabs|May 25, 2010
5-azacytidine enhances the anti-leukemic activity of lintuzumab (SGN-33) in preclinical models of acute myeloid leukemiaMay Kung Sutherland, Changpu Yu, Martha Anderson, et al.
The Cancer Journal From Scientific American|February 24, 2000
Children's cancer group trials of interleukin-2 therapy to prevent relapse of acute myelogenous leukemiaE L Sievers, B J Lange, P M Sondel, et al.
Arthritis and Rheumatism|May 16, 2001
Joint swelling as a predictor of death from cardiovascular disease in a population study of Pima IndiansL T Jacobsson, C Turesson, R L Hanson, et al.
Blood|December 1, 1996
Patterns of hematopoietic lineage involvement in children with neurofibromatosis type 1 and malignant myeloid disordersD K Miles, M H Freedman, K Stephens, et al.
The Journal of Clinical Endocrinology and Metabolism|April 1, 1983
Hypergastrinemia in obese noninsulin-dependent diabetes: a possible reflection of high prevalence of vagal dysfunctionH Sasaki, M Nagulesparan, A Dubois, et al.
Cancer Immunology, Immunotherapy : CII|September 14, 2021
The pivotal role of cytotoxic NK cells in mediating the therapeutic effect of anti-CD47 therapy in mycosis fungoidesOleg Kruglov, Lisa D S Johnson, Angela Minic, et al.
Pediatric Blood & Cancer|June 18, 2011
Soluble interleukin-2 receptor α activation in a Children's Oncology Group randomized trial of interleukin-2 therapy for pediatric acute myeloid leukemiaBeverly J Lange, Richard K Yang, Jacek Gan, et al.
Pageof 14